Volume 2, Emitir 4 (2012)
Revisão: Resultados da Trilha Clínica
Peripheral T-cell lymphoma: pharmacotherapy overview
Maher Abdul-Hay, Jasmine Zain
Perspectiva Terapêutica
Therapeutic potential of hedgehog signaling inhibitors in cancer: rationale and clinical data
Blake T Aftab, Charles M Rudin
Perspectiva Terapêutica
Src tyrosine kinase inhibitors in the treatment of lung cancer: rationale and clinical data
Sacha I Rothschild,Oliver Gautschi
Revisão: Resultados da Trilha Clínica
New developments in the treatment of chronic thromboembolic pulmonary hypertension*** Pharmacological treatment of CTEPH
Irene M Lang
Revisão: Resultados da Trilha Clínica
IL-17 in systemic lupus erythematosus
Wu Qian, Antonio La Cava
Revisão: Resultados da Trilha Clínica
Approaches to clinical trials of new anti-tuberculous drugs
Charles M Bark, Jennifer J Furin & John L Johnson
Revisão: Resultados da Trilha Clínica
Ranibizumab for the treatment of visual impairment due to diabetic macular edema: evidence from recent clinical trials
Laura Distefano, Anna Espax Boixadera, Charlotte Wolley-Dod, Vicente Martnez-Castillo, Jose Garcia-Arumi
Entrevista
Ethical issues of placebo-controlled clinical trials in multiple sclerosis
Jeffrey A Cohen
Revisão: Resultados da Trilha Clínica
Safety and efficacy of transdermal testosterone for treatment of hypoactive sexual desire disorder
Talya Waldman, Chrisandra L Shufelt, Glenn D Braunstein
